| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Lawrence J Jasinski is Chief Executive Officer at LFWD, with reported holdings spanning 2 companies. Lawrence J Jasinski's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $978K at current prices.
Our model assigns Lawrence J Jasinski a middling insider score of 63/100, based on 19 past trades. Over a 12-month horizon, 55.6% of those trades were profitable, with an average 12-month return of +19.6%.
Lawrence J Jasinski's largest disclosed position is in LFWD as Chief Executive Officer, worth about $598K. The LFWD filings lean toward selling, a net 73,632 shares.
Lawrence J Jasinski has 105 Form 4 filings on record from July 2015 to September 2026, across 2 companies: Director at LeMaitre Vascular (LMAT), 2015–2026; Chief Executive Officer at Lifeward (LFWD), 2016–2025.
The 208 reported transactions were 77 option or other derivative awards, 42 option exercises, 42 open-market sales and 26 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $11K and 36 sales worth about $3.8M.
The only open-market purchase was 15,000 shares of LFWD at an average $0.72 on March 15, 2023, about $11K. Twelve months later LFWD was down 17%.
The largest open-market sale was 10,000 shares of LMAT at an average $47.07 on December 2, 2022, about $471K. Twelve months later LMAT was up 14%.
2 of the 14 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 12 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | LMAT Lemaitre Vascular, Inc. | Director | Sale+OE | 3,943 | $110.00 | $433,730.00 | -45.5% | -26.8% | - | |
| Aug 12, 2025 | LMAT Lemaitre Vascular Inc | Director | Sell | 976 | $92.78 | $90,553.28 | -17.0% | -7.0% | -13.0% | |
| May 21, 2025 | LFWD Lifeward Ltd. | Chief Executive Officer | Sell | 1,909 | $1.26 | $2,405.34 | -1.9% | -48.4% | -55.6% | |
| Mar 4, 2025 | LMAT Lemaitre Vascular Inc | Director | Sell | 3,142 | $92.00 | $289,064.00 | -54.7% | -11.1% | +17.7% | |
| Nov 20, 2024 | LMAT Lemaitre Vascular Inc | Director | Sell | 198 | $103.50 | $20,493.00 | -3.7% | -2.6% | -18.4% | |
| Sep 13, 2024 | LFWD Lifeward Ltd. | Chief Executive Officer | Sell | 2,672 | $3.26 | $8,700.03 | -2.6% | -49.1% | -82.5% | |
| Aug 2, 2024 | LFWD Lifeward Ltd. | Chief Executive Officer | Sell | 2,665 | $3.84 | $10,233.60 | -2.5% | -42.1% | -81.7% | |
| Jun 18, 2024 | LFWD Lifeward Ltd. | Chief Executive Officer | Sell | 3,466 | $4.22 | $14,617.16 | -3.2% | -24.5% | -74.6% | |
| May 21, 2024 | LFWD Lifeward Ltd. | Chief Executive Officer | Sell | 1,620 | $4.91 | $7,954.20 | -1.5% | -27.0% | -76.5% | |
| Mar 5, 2024 | LMAT Lemaitre Vascular Inc | Director | Sell | 5,110 | $67.50 | $344,925.00 | -49.0% | +16.5% | +29.0% |